Beauty Device Standards: New Rules for 2026

The recent P&G ruling in Italy marks a significant shift in how at-home hair removal devices are regulated, establishing stricter standards for safety and efficacy. This decision has sent ripples through the beauty industry, challenging manufacturers to re-evaluate their product development and marketing strategies. Misinformation abounds regarding what this ruling truly means for consumers and the future of at-home device standards.

Myth 1: The ruling only affects P&G products.

This is a widespread misunderstanding. While the legal action involved P&G, the Italian Competition Authority (AGCM) ruling sets a precedent that extends far beyond a single company. The AGCM’s decision, issued on October 25, 2025, specifically addresses the advertising claims made for certain intense pulsed light (IPL) devices, finding them to be unsubstantiated regarding their promised efficacy for permanent hair removal. The core of the ruling is about consumer protection and ensuring that claims made about at-home devices are backed by verifiable scientific evidence. This means any manufacturer selling similar devices in Italy, or indeed across the European Union if this precedent gains wider traction, must now review their claims and ensure they align with the new, higher bar for proof. It’s not a targeted attack on one brand. It’s a systemic push for greater transparency and accountability across the entire at-home beauty device sector.

Myth 2: At-home devices are now considered unsafe.

The ruling does not declare at-home hair removal devices inherently unsafe. Instead, it scrutinizes the claims made about their performance. Many at-home devices, particularly those using IPL technology, are generally considered safe when used according to manufacturer instructions. The issue arises when marketing language overstates their capabilities, leading consumers to expect results akin to professional treatments that use different technologies or higher energy levels. For instance, a report by the European Society for Laser Dermatology (ESLD) from 2024 emphasized that while adverse events from at-home IPL are rare, they often stem from improper use or unrealistic expectations fueled by marketing. The AGCM ruling aims to align consumer expectations with actual device performance, ensuring that safety is paired with truthful efficacy claims. It’s about setting a realistic benchmark, not condemning an entire category of products.

Myth 3: Professional waxing is obsolete because at-home devices offer the same results.

This myth persists despite clear differences in technology and application. Professional waxing, whether using soft wax or hard wax, removes hair directly from the follicle, providing immediate smoothness that lasts for weeks. At-home devices, particularly IPL, work by targeting the melanin in the hair follicle to inhibit future hair growth. The mechanisms are fundamentally different. While some at-home IPL devices can offer significant hair reduction over time, they typically require consistent, long-term use and often do not achieve the same degree of permanence or speed of results as professional laser hair removal treatments. Think of it this way: a professional laser session uses medical-grade equipment operated by trained specialists, delivering precise energy levels that are significantly higher than what is available in consumer devices. The AGCM ruling implicitly reinforces this distinction by demanding stricter proof for “permanent” hair removal claims from at-home devices, acknowledging the gap that often exists between consumer-grade and professional-grade solutions.

Myth 4: All at-home hair removal devices will be banned.

There is no indication that a blanket ban on at-home hair removal devices is forthcoming. The P&G ruling focuses on the substantiation of claims, not the outright prohibition of products. Manufacturers will need to adjust their advertising and potentially their product specifications to meet the new regulatory environment. This could mean more conservative marketing language, clearer disclaimers about expected results, or even enhanced device capabilities backed by rigorous clinical trials. The goal is to protect consumers from misleading information, not to remove product options from the market. The market for at-home beauty devices is strong, and innovation continues. According to a 2025 market analysis by Euromonitor International, the global at-home beauty device market is projected to grow by 8% annually, suggesting continued consumer demand. This growth will likely drive manufacturers to invest more in research and development to meet heightened regulatory scrutiny, rather than withdraw from the market entirely.

Myth 5: The ruling won’t impact devices sold outside of Italy.

While the AGCM ruling directly applies to the Italian market, its implications are far-reaching. Regulatory decisions in one European Union member state often influence others, particularly when they pertain to consumer protection and product safety. The principle of mutual recognition within the EU means that products lawfully sold in one member state can generally be sold in another. However, if a product’s marketing claims are deemed misleading in one country, it creates a precedent that other national authorities can reference. We’ve seen this happen with other consumer product regulations. The European Commission often looks to national rulings as indicators for potential EU-wide harmonization efforts. Manufacturers operating across Europe, therefore, are wise to consider the Italian ruling as a bellwether for future regulatory trends. Companies will likely proactively revise their marketing strategies across all European markets to avoid similar issues, ensuring greater consistency and transparency for consumers everywhere.

Myth 6: Consumers have no way to verify product claims.

This is simply not true. While it requires a bit of diligence, consumers have several avenues to verify product claims. First, look for devices that clearly state they have undergone independent clinical testing. Reputable manufacturers will often publish summaries of these studies on their websites or provide links to peer-reviewed journals. Second, consult consumer advocacy groups or regulatory bodies. For example, the European Consumer Organisation (BEUC) frequently publishes reports on product safety and misleading marketing. Third, scrutinize the language used in advertising. Terms like “permanent” or “miracle” should raise immediate red flags, especially if they are not accompanied by specific data or caveats. If a product promises results that seem too good to be true, they probably are. The AGCM ruling helps consumers by demanding more evidence from manufacturers, making it easier to distinguish between legitimate claims and marketing hyperbole. Always prioritize devices that provide clear, scientific backing for their performance. The Italian P&G ruling represents a key moment for the at-home beauty device industry, demanding greater transparency and scientific rigor from manufacturers. Consumers should interpret this not as a limitation, but as an empowerment, fostering an environment where trust is built on verifiable evidence and realistic expectations.